Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

912.87
-16.8550-1.81%
Volume:2.38M
Turnover:2.18B
Market Cap:865.55B
PE:77.96
High:931.38
Open:920.01
Low:898.28
Close:929.72
Loading ...

Jim Cramer on Eli Lilly and Company (LLY): ‘Eli Lilly Cutting The Price Is Gonna Make It So That It Is Dramatically Good’

Insider Monkey
·
01 Mar

Eli Lilly's (NYSE:LLY) Earnings May Just Be The Starting Point

Simply Wall St.
·
01 Mar

India's Sun Pharma aims to launch its obesity drug in five years, managing director says

Reuters
·
01 Mar

Eli Lilly takes aim at weight-loss drug copies with new ad campaign

Reuters
·
28 Feb

Lilly to participate in Leerink Partners Global Healthcare Conference

PR Newswire
·
28 Feb

Pharma Stock Roundup: LLY Ups U.S. Manufacturing Investments & More

Zacks
·
28 Feb

Drug Stocks Are the New Safe Bet in a Shaky Market

Dow Jones
·
28 Feb

Eli Lilly Gets CHMP Backing of Jaypirca in Chronic Lymphocytic Leukemia

Dow Jones
·
28 Feb

Eli Lilly Says Jaypirca Recommended for EU Approval to Treat Leukemia

MT Newswires Live
·
28 Feb

Behind Hims Stock's Roller-Coaster Ride As Weight-Loss Drugs Battle Heats Up

Blockhead
·
28 Feb

Lilly's Jaypirca (Pirtobrutinib) Recommended by Chmp for Approval in the European Union for Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (Cll) Previously Treated With a Btk Inhibitor

THOMSON REUTERS
·
28 Feb

Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) previously treated with a BTK inhibitor

PR Newswire
·
28 Feb

Magnet Biomedicine: to Receive up to $40 Mln in Upfront Payments, Equity Investment, Additional Milestones Potentially Totaling Over $1.25 Bln

THOMSON REUTERS
·
28 Feb

Magnet Biomedicine: Enters Into a Collaboration and License Agreement With Lilly to Discover and Develop Novel Molecular Glue Medicines

THOMSON REUTERS
·
28 Feb

Eli Lilly's big investment, cheaper Zepbound, and Hims & Hers' options: Pharma news roundup

Quartz
·
28 Feb

Top Research Reports for Amazon, Eli Lilly & S&P Global

Zacks
·
28 Feb